Cargando…
Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922410/ https://www.ncbi.nlm.nih.gov/pubmed/29721216 http://dx.doi.org/10.18632/oncotarget.25151 |
| _version_ | 1783318196259913728 |
|---|---|
| author | Arend, Rebecca C. Londoño-Joshi, Angelina I. Gangrade, Abhishek Katre, Ashwini A. Kurpad, Chandrika Li, Yonghe Samant, Rajeev S. Li, Pui-Kai Landen, Charles N. Yang, Eddy S. Hidalgo, Bertha Alvarez, Ronald D. Straughn, John Michael Forero, Andres Buchsbaum, Donald J. |
| author_facet | Arend, Rebecca C. Londoño-Joshi, Angelina I. Gangrade, Abhishek Katre, Ashwini A. Kurpad, Chandrika Li, Yonghe Samant, Rajeev S. Li, Pui-Kai Landen, Charles N. Yang, Eddy S. Hidalgo, Bertha Alvarez, Ronald D. Straughn, John Michael Forero, Andres Buchsbaum, Donald J. |
| author_sort | Arend, Rebecca C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5922410 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59224102018-05-02 Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer Arend, Rebecca C. Londoño-Joshi, Angelina I. Gangrade, Abhishek Katre, Ashwini A. Kurpad, Chandrika Li, Yonghe Samant, Rajeev S. Li, Pui-Kai Landen, Charles N. Yang, Eddy S. Hidalgo, Bertha Alvarez, Ronald D. Straughn, John Michael Forero, Andres Buchsbaum, Donald J. Oncotarget Correction Impact Journals LLC 2018-04-10 /pmc/articles/PMC5922410/ /pubmed/29721216 http://dx.doi.org/10.18632/oncotarget.25151 Text en Copyright: © 2018 Arend et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Arend, Rebecca C. Londoño-Joshi, Angelina I. Gangrade, Abhishek Katre, Ashwini A. Kurpad, Chandrika Li, Yonghe Samant, Rajeev S. Li, Pui-Kai Landen, Charles N. Yang, Eddy S. Hidalgo, Bertha Alvarez, Ronald D. Straughn, John Michael Forero, Andres Buchsbaum, Donald J. Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer |
| title | Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer |
| title_full | Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer |
| title_fullStr | Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer |
| title_full_unstemmed | Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer |
| title_short | Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer |
| title_sort | correction: niclosamide and its analogs are potent inhibitors of wnt/β-catenin, mtor and stat3 signaling in ovarian cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922410/ https://www.ncbi.nlm.nih.gov/pubmed/29721216 http://dx.doi.org/10.18632/oncotarget.25151 |
| work_keys_str_mv | AT arendrebeccac correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT londonojoshiangelinai correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT gangradeabhishek correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT katreashwinia correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT kurpadchandrika correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT liyonghe correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT samantrajeevs correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT lipuikai correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT landencharlesn correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT yangeddys correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT hidalgobertha correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT alvarezronaldd correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT straughnjohnmichael correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT foreroandres correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer AT buchsbaumdonaldj correctionniclosamideanditsanalogsarepotentinhibitorsofwntbcateninmtorandstat3signalinginovariancancer |